Skip to content

About us
Team
- Founders
- Management
Study Area
Pipeline & therapeutic areas
Partnerships
News
Contact

Fundraising

SkinDermic has raised 800 k€ via a “Friends&Family” investment in November 2018.

Post navigation

← Previous Post

News SkinDermic announces very good results of the SDK 001 compound in the treatment of Kaposis sarcoma.SkinDermic announces very good results of the SDA 001 compound in the treatment of acne.Skindermic signed with SATT Idfinnov

About us
Origins
Objectives
Discoveries and patents
Strategy
Location

Team
Founders
Management

Study Area
Acne
Kaposi’s Sarcoma
Skin-Depigmenting

Pipeline & therapeutic areas

Partnerships

News

Contact

©2024 SkinDermic - Legal Notice - LinkedIn